Castle Biosciences Inc. trailing returns
How Castle Biosciences Inc. (CSTL) has performed over the last day, week, month and year, over 5 years, and since inception, through October 20, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-20. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | +3.1% | +0.0% | +3.1% | — |
| 5 days | +0.8% | +0.0% | +0.8% | -5.4%Oct 16 |
| 1 month | -6.2% | +0.0% | -6.2% | -12.8%Oct 16 |
| YTD | -14.8% | +0.0% | -14.8% | -57.8%May 13 |
| 1 year | +44.1% | +0.0% | +44.1% | -57.8%May 2026 |
| 5 years | -12.6% | +0.0% | -12.6%-49.0% | -82.1%Jun 2023 |
| Since inception (2019) | +6.2% | +0.0% | +6.2%+54.9% | -88.0%Jun 2023 |
Growth of CSTL#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years-12.6%/year · -49.0%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-20). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in CSTL's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Castle Biosciences Inc.'s return since inception?
- Since 2019, Castle Biosciences Inc. (CSTL) has compounded at about +6.2% a year — +54.9% in total.